The pathological diagnosis was invasive ductal carcinoma, histological grade 2, estrogen receptor (ER) negative, progesterone receptor (PgR) negative, and human epidermal receptor 2 (HER2) negative (score 1+). This evidence concerns the gene PGR and invasive ductal breast carcinoma.